StemGrow® Hair Loss Protocol
Advances in Regenerative Medicine for Hair Loss
The recent development of U-MSC-derived exosome therapies offers an alternative option for hair loss treatment.
Targeting the Underlying Causes of Hair Loss and Alopecia
Alopecia and hair loss impact individuals globally. However, recent advancements in U-MSC-derived exosome therapies, combined with intravenous U-MSC treatments, offer a biologically compatible approach to hair restoration.
The combination of U-MSC therapies and the targeted application of U-MSC-derived exosomes to the scalp promotes hair regrowth by addressing the underlying biological factors of hair loss and alopecia. This approach aims to stimulate hair follicles and reduce inflammation, supporting the conditions necessary for effective hair restoration.
Growth Factors
U-MSC exosomes release growth factors like VEGF and PDGF, which stimulate hair follicles, promote hair growth, and extend the hair cycle’s growth phase.
Inflammation Reduction
Conditions like alopecia areata are linked to inflammation. U-MSC therapies reduce inflammation at the follicular level, promoting a healthier scalp.
Cellular Differentiation
By influencing cell behavior, U-MSC Stem Cells and exosomes work to reverse hair follicle dormancy, encouraging natural regrowth.
Harnessing the Potential of U-MSC Stem Cell Derived Exosomes
U-MSC-based therapies are rooted in science and offer evidence-based solutions to address hair loss. These therapies leverage the body’s natural repair mechanisms, ensuring minimal adverse reactions and a biologically harmonious response.
This innovative approach supports hair restoration with a focus on biological compatibility and research-backed effectiveness.
Regenerative Medicine for Hair Restoration
As the potential of U-MSC-derived exosomes continues to gain recognition, their role in hair follicle regeneration offers new possibilities for those affected by hair loss and alopecia. This breakthrough therapy reactivates dormant follicles, providing a new pathway to hair restoration.
U-MSC
U-MSCs are multipotent cells that can differentiate into a variety of cell types, making them highly valuable in regenerative treatments. Their ability to support tissue repair and regeneration plays a key role in addressing hair loss.
U-MSC Derived Exosomes
Exosomes are nanometric vesicles released by U-MSCs that facilitate intercellular communication. Loaded with proteins, growth factors, and other signaling molecules, these exosomes help stimulate hair follicle activity.
Yuan, An-Ran; Bian, Qiong; Gao, Jian-Qing
Current advances in stem cell-based therapies for hair regeneration Journal Article
In: 2020.
@article{nokey,
title = {Current advances in stem cell-based therapies for hair regeneration},
author = {An-Ran Yuan and Qiong Bian and Jian-Qing Gao},
url = {https://doi.org/10.1016/j.ejphar.2020.173197},
year = {2020},
date = {2020-08-15},
abstract = {Alopecia is resulted from various factors that can decrease the regeneration capability of hair follicles and affect hair cycles. This process can be devastating physically and psychologically. Nevertheless, the available treatment strategies are limited, and the therapeutic outcomes are not satisfactory. According to the possible pathogenesis of nonscarring alopecia, especially androgenetic alopecia, recovering or replenishing the signals responsible for hair follicle stem cells activation is a promising strategy for hair regeneration. Recently, stem cell-based therapies, especially those based on the stem cell-derived conditioned medium (CM), which is secreted by stem cells and is rich in paracrine factors, have been widely explored as the hair regenerative medicine. Several studies have focused on altering the composition and up-regulating the amount of secretome of the stem cells, thereby enhancing its therapeutic effects. Besides, stem cell-derived exosomes, which are present in the CM as message entities, are also promising for hair regrowth. In this review, the up-to-date progress of research efforts focused on stem cell-based therapies for hair regeneration will be discussed, including their therapeutic potentials with respective merits and demerits, as well as the possible mechanisms.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Chen, Chih-Lung; Huang, Wen-Yen; Wang, Eddy Hsi Chun; Tai, Kang-Yu; Lin, Sung-Jan
Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration Journal Article
In: 2020.
@article{nokey,
title = {Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration},
author = {Chih-Lung Chen and Wen-Yen Huang and Eddy Hsi Chun Wang and Kang-Yu Tai and Sung-Jan Lin},
url = {https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-020-0624-8},
year = {2020},
date = {2020-03-14},
abstract = {Stem cell activity is subject to non-cell-autonomous regulation from the local microenvironment, or niche. In adaption to varying physiological conditions and the ever-changing external environment, the stem cell niche has evolved with multifunctionality that enables stem cells to detect these changes and to communicate with remote cells/tissues to tailor their activity for organismal needs. The cyclic growth of hair follicles is powered by hair follicle stem cells (HFSCs). Using HFSCs as a model, we categorize niche cells into 3 functional modules, including signaling, sensing and message-relaying. Signaling modules, such as dermal papilla cells, immune cells and adipocytes, regulate HFSC activity through short-range cell-cell contact or paracrine effects. Macrophages capacitate the HFSC niche to sense tissue injury and mechanical cues and adipocytes seem to modulate HFSC activity in response to systemic nutritional states. Sympathetic nerves implement the message-relaying function by transmitting external light signals through an ipRGC-SCN-sympathetic circuit to facilitate hair regeneration. Hair growth can be disrupted by niche pathology, e.g. dysfunction of dermal papilla cells in androgenetic alopecia and influx of auto-reacting T cells in alopecia areata and lichen planopilaris. Understanding the functions and pathological changes of the HFSC niche can provide new insight for the treatment of hair loss.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Gentile, Pietro; Garcovich, Simone
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss Journal Article
In: 2019.
@article{nokey,
title = {Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss},
author = {Pietro Gentile and Simone Garcovich},
url = {https://doi.org/10.3390/cells8050466},
year = {2019},
date = {2019-05-16},
urldate = {2019-05-16},
abstract = {The use of stem cells has been reported to improve hair regrowth in several therapeutic strategies, including reversing the pathological mechanisms, that contribute to hair loss, regeneration of hair follicles, or creating hair using the tissue-engineering approach. Although various promising stem cell approaches are progressing via pre-clinical models to clinical trials, intraoperative stem cell treatments with a one-step procedure offer a quicker result by incorporating an autologous cell source without manipulation, which may be injected by surgeons through a well-established clinical practice. Many authors have concentrated on adipose-derived stromal vascular cells due to their ability to separate into numerous cell genealogies, platelet-rich plasma for its ability to enhance cell multiplication and neo-angiogenesis, as well as human follicle mesenchymal stem cells. In this paper, the significant improvements in intraoperative stem cell approaches, from in vivo models to clinical investigations, are reviewed. The potential regenerative instruments and functions of various cell populaces in the hair regrowth process are discussed. The addition of Wnt signaling in dermal papilla cells is considered a key factor in stimulating hair growth. Mesenchymal stem cell-derived signaling and growth factors obtained by platelets influence hair growth through cellular proliferation to prolong the anagen phase (FGF-7), induce cell growth (ERK activation), stimulate hair follicle development (β-catenin), and suppress apoptotic cues (Bcl-2 release and Akt activation).},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Yuan, An-Ran; Bian, Qiong; Gao, Jian-Qing
Current advances in stem cell-based therapies for hair regeneration Journal Article
In: 2020.
@article{nokey,
title = {Current advances in stem cell-based therapies for hair regeneration},
author = {An-Ran Yuan and Qiong Bian and Jian-Qing Gao},
url = {https://doi.org/10.1016/j.ejphar.2020.173197},
year = {2020},
date = {2020-08-15},
abstract = {Alopecia is resulted from various factors that can decrease the regeneration capability of hair follicles and affect hair cycles. This process can be devastating physically and psychologically. Nevertheless, the available treatment strategies are limited, and the therapeutic outcomes are not satisfactory. According to the possible pathogenesis of nonscarring alopecia, especially androgenetic alopecia, recovering or replenishing the signals responsible for hair follicle stem cells activation is a promising strategy for hair regeneration. Recently, stem cell-based therapies, especially those based on the stem cell-derived conditioned medium (CM), which is secreted by stem cells and is rich in paracrine factors, have been widely explored as the hair regenerative medicine. Several studies have focused on altering the composition and up-regulating the amount of secretome of the stem cells, thereby enhancing its therapeutic effects. Besides, stem cell-derived exosomes, which are present in the CM as message entities, are also promising for hair regrowth. In this review, the up-to-date progress of research efforts focused on stem cell-based therapies for hair regeneration will be discussed, including their therapeutic potentials with respective merits and demerits, as well as the possible mechanisms.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Chen, Chih-Lung; Huang, Wen-Yen; Wang, Eddy Hsi Chun; Tai, Kang-Yu; Lin, Sung-Jan
Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration Journal Article
In: 2020.
@article{nokey,
title = {Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration},
author = {Chih-Lung Chen and Wen-Yen Huang and Eddy Hsi Chun Wang and Kang-Yu Tai and Sung-Jan Lin},
url = {https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-020-0624-8},
year = {2020},
date = {2020-03-14},
abstract = {Stem cell activity is subject to non-cell-autonomous regulation from the local microenvironment, or niche. In adaption to varying physiological conditions and the ever-changing external environment, the stem cell niche has evolved with multifunctionality that enables stem cells to detect these changes and to communicate with remote cells/tissues to tailor their activity for organismal needs. The cyclic growth of hair follicles is powered by hair follicle stem cells (HFSCs). Using HFSCs as a model, we categorize niche cells into 3 functional modules, including signaling, sensing and message-relaying. Signaling modules, such as dermal papilla cells, immune cells and adipocytes, regulate HFSC activity through short-range cell-cell contact or paracrine effects. Macrophages capacitate the HFSC niche to sense tissue injury and mechanical cues and adipocytes seem to modulate HFSC activity in response to systemic nutritional states. Sympathetic nerves implement the message-relaying function by transmitting external light signals through an ipRGC-SCN-sympathetic circuit to facilitate hair regeneration. Hair growth can be disrupted by niche pathology, e.g. dysfunction of dermal papilla cells in androgenetic alopecia and influx of auto-reacting T cells in alopecia areata and lichen planopilaris. Understanding the functions and pathological changes of the HFSC niche can provide new insight for the treatment of hair loss.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Gentile, Pietro; Garcovich, Simone
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss Journal Article
In: 2019.
@article{nokey,
title = {Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss},
author = {Pietro Gentile and Simone Garcovich},
url = {https://doi.org/10.3390/cells8050466},
year = {2019},
date = {2019-05-16},
urldate = {2019-05-16},
abstract = {The use of stem cells has been reported to improve hair regrowth in several therapeutic strategies, including reversing the pathological mechanisms, that contribute to hair loss, regeneration of hair follicles, or creating hair using the tissue-engineering approach. Although various promising stem cell approaches are progressing via pre-clinical models to clinical trials, intraoperative stem cell treatments with a one-step procedure offer a quicker result by incorporating an autologous cell source without manipulation, which may be injected by surgeons through a well-established clinical practice. Many authors have concentrated on adipose-derived stromal vascular cells due to their ability to separate into numerous cell genealogies, platelet-rich plasma for its ability to enhance cell multiplication and neo-angiogenesis, as well as human follicle mesenchymal stem cells. In this paper, the significant improvements in intraoperative stem cell approaches, from in vivo models to clinical investigations, are reviewed. The potential regenerative instruments and functions of various cell populaces in the hair regrowth process are discussed. The addition of Wnt signaling in dermal papilla cells is considered a key factor in stimulating hair growth. Mesenchymal stem cell-derived signaling and growth factors obtained by platelets influence hair growth through cellular proliferation to prolong the anagen phase (FGF-7), induce cell growth (ERK activation), stimulate hair follicle development (β-catenin), and suppress apoptotic cues (Bcl-2 release and Akt activation).},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Complete the form to receive detailed information about regenerative medicine therapy for hair loss
- Secure HIPAA Compliant
- 48 Hours Response
- No Obligations
GETTING STARTED
Start by filling out our Pre Screening Questionnaire and a member of our team will reach out to discuss your interest and answer any initial questions.
PATIENT INTAKE QUESTIONNAIRE
Please fill out the patient intake questionnaire. This information will help our team better understand your medical history and needs.
SCHEDULE A VIDEO CONSULTATION
Book a video consultation with our medical team. During this consultation, you may be asked to provide any relevant medical records or images for review.
Final Review
Our team will conduct a final review of your case, and we will outline the recommended next steps based on your consultation and submitted information.
OmniStem Cell-based Therapies
Frequently Asked Questions
Please explore our Resource Center for helpful information. If you have any additional questions, feel free to contact our patient care team for assistance.
Umbilical cord mesenchymal stem cells (U-MSCs) are a type of adult stem cell found in Wharton’s jelly, a gelatinous substance within the umbilical cord. These cells have the ability to differentiate into various cell types, such as bone, cartilage, and fat cells, making them highly valuable for regenerative medicine and cell therapies.
Exosomes are microscopic, sac-like vesicles naturally released by cells, containing a rich payload of proteins, RNA, and other biomolecules essential for cellular communication and repair. Typically 30–200 nanometers in size, these extracellular vesicles play a pivotal role in maintaining and restoring cellular health.
At OmniStem, we harness the therapeutic potential of exosomes derived from umbilical cord mesenchymal stem cells (U-MSCs). These exosomes act as messengers, delivering regenerative signals to damaged tissues to support healing and reduce inflammation.
U-MSC stem cell treatments are considered specialized and are generally not covered by insurance plans.
U-MSC-derived allogenic stem cell therapies are currently not allowed in the U.S.
While mesenchymal stem cells (U-MSCs) have received FDA approval, the FDA does not permit the expansion of allogenic stem cells. As a result, patients undergoing these therapies in the U.S. typically receive a limited number of cells, which may reduce the potential benefits, including the use of U-MSC-derived exosomes.
At OmniStem, we use a safe and controlled laboratory process to expand these cells, enabling us to administer tens of millions of U-MSCs and U-MSC exosomes to our patients. This approach significantly enhances treatment outcomes.
This is a key reason many individuals travel to countries like Colombia, Panamá, Mexico, and the Dominican Republic to seek recognized providers of the most advanced regenerative medicine biologics available.
Our main facilities are located in the city of Pereira, in Colombia. We have specialized clinics and application centers for stem cell treatments that comply with all biosafety protocols and the highest safety standards. Pereira is the capital of the Colombian coffee region, one of the wonders of tourism in the country, and a World Heritage Site declared by UNESCO.